UAE mandates AED 50,000 minimum fine for controlled substance violations

The UAE government recently amended the federal law on combating narcotic drugs and psychotropic substances, establishing a minimum penalty of AED 50,000 for specific record-keeping violations. Private healthcare operators must audit their current compliance frameworks to meet these new standards for the prescription, storage, and dispensing of controlled medications.

Medical directors and pharmacy managers bear direct legal responsibility for the administration of psychotropic drugs under these revisions. The Ministry of Health and Prevention (MOHAP) oversees compliance in the Northern Emirates, while the Dubai Health Authority (DHA) and the Department of Health – Abu Dhabi (DoH) maintain jurisdiction in their respective areas. Failure to document the movement of these substances triggers financial penalties and potential custodial sentences for the license holder.

Healthcare organizations require an immediate review of inventory management systems and electronic health record (EHR) audit logs. CFOs should budget for the increased risk associated with documentation errors, as penalties for administrative lapses start at AED 50,000. IT departments must verify that software providers include automated alerts for stock reconciliation to reduce human error. Clinical staff require updated training sessions on the new protocols to protect the facility during regulatory inspections.

Facilities using centralized procurement must verify that all supply chain partners maintain valid licensing for the transport of controlled substances. Failure to ensure vendor compliance creates an operational risk for the purchasing hospital. MOHAP, DHA, and DoH monitor prescription patterns through centralized digital databases to detect irregularities in physician prescribing habits.